HIV/AIDS - Research and Palliative Care
The following Article Collection/ Thematic Series is currently open for submissions:
HIV: treatments and prevention for longevity
Dove Medical Press is pleased to invite you to submit your research to an upcoming Thematic Series on “HIV: treatments and prevention for longevity”, edited by Editor-in-Chief Prof. Dr. Olubunmi Ogunrin in HIV/AIDS - Research and Palliative Care.
Upon submission, please use the promo code JBJFT for 20% off the advertised article processing charge and indicate that your manuscript will be considered for the Thematic Series of “HIV: treatments and prevention for longevity”. The deadline for manuscripts is the 15th of September 2022.
For any enquiries, please email Darcy Hodge, Commissioning Editor at [email protected]
About the Thematic Series
For many researchers and clinicians, effective prevention and treatment of HIV can prove a halfway point for its eradication. Since its first outbreak, the developments made highlight a wealth of progress, but how much further does medical science have to go? This Thematic Series will explore current methods to prevent the spread of HIV, alongside those currently in development. This can include the varying types of HIV vaccine in development (e.g., mRNA, T-Cell), our understanding of selective immunity in certain individuals, the efficacy of pre-exposure prophylaxis and more.
Prevention is one part of reducing the spread of HIV, but the treatments available to patients once diagnosed are equally as important. Recent developments and discoveries in HIV treatment push the field further to improve the quality of life of individuals living with HIV, including progress into injectable treatments. Additionally, pre-existing treatments including antiretroviral drugs receive necessary updates to enhance their efficacy, safety and adherence levels.
Importantly, how clinicians and society approach HIV and its treatment is crucial for progress. This includes highlighting the accessibility of HIV healthcare across countries, gender, socioeconomic status and age groups. With this information it is hoped that everyone has a chance of receiving high-quality HIV healthcare globally. Attitudes can form a significant part of this, as the benefits of having an external support network will also be explored in this Thematic Series. However, the mental health of the patient can be equally as important as external support, with insight into psychological comorbidities and treatments available to individuals living with HIV.
The journal is seeking original submissions and review articles on the following topics related to the prevention, treatment and attitudes towards HIV:
• Latest developments in HIV treatment, including long-acting injectable treatments
• Knowledge about current antiretroviral drugs and microbicides
• Impact of genetics on variability in HIV transmission and treatment
• Cases of cured HIV and how they can inform treatment
• Selective immunity against HIV in special populations
• Progress and challenges in various types of HIV vaccine development
• Variables in the efficacy of pre-exposure prophylaxis (PrEP)
• Environmental and societal methods for HIV prevention
• Accessibility of HIV treatment worldwide and across sociodemographic groups
• Attitudes towards HIV and their impacts on treatment uptake and adherence
• The power of social support networks
• Mental health of individuals living with HIV throughout different stages of treatment
• Psychological comorbidities and psychiatric treatments in HIV care
Submit your manuscript
Call For Papers
To see where HIV/AIDS - Research and Palliative Care is indexed online view the Journal Metrics.
What is the advantage to you of publishing in HIV/AIDS - Research and Palliative Care?
- It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the Dove website.
- Unlike many traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
- The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. HIV/AIDS - Research and Palliative Care has a quicker turnaround time than this. Generally peer review is complete within 3-4 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 6 weeks for first editorial decision.
- Many authors have found that our peer reviewer’s comments substantially add to their final papers.
To recover our editorial and production costs and continue to provide our content at no cost to readers we charge authors or their institution a publication processing fee.
HIV/AIDS - Research and Palliative Care is indexed on PubMed Central (title abbreviation: (HIV AIDS (Auckl)). All published papers in this journal are submitted to PubMed for indexing straight away.
Become a Favored Author and receive real benefits
If you haven't already joined the Dove Press Favored Author Program I would encourage you to do so. Why? To receive real benefits like fast-tracking and a personal co-ordinator for your paper, as well as a discount on the publication processing fee.
Click here to go through to the Favored Author signup page, you'll just need to supply the working title of your next paper and when you intend to submit by.
Prof. Dr. Ogunrin
HIV/AIDS - Research and Palliative Care